Evaluation of 1,25-dihydroxyvitamin D3 pathway in patients with chronic urticaria
QJM: An International Journal of Medicine Dec 07, 2017
Nasiri-Kalmarzi R, et al. - As a part of this study, the vitamin (Vit) pathway and the link between vitamin D receptor (VDR) and vitamin D binding protein (VDBP) gene polymorphisms and chronic urticaria (CU) risk were assessed in this trial, among Iranian cohort. It was deduced that the change in vitamin D (Vit D) pathway in the level of gene or protein could serve as a risk factor for the progression of CU.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries